{"@context":{"@vocab":"https://cir.nii.ac.jp/schema/1.0/","rdfs":"http://www.w3.org/2000/01/rdf-schema#","dc":"http://purl.org/dc/elements/1.1/","dcterms":"http://purl.org/dc/terms/","foaf":"http://xmlns.com/foaf/0.1/","prism":"http://prismstandard.org/namespaces/basic/2.0/","cinii":"http://ci.nii.ac.jp/ns/1.0/","datacite":"https://schema.datacite.org/meta/kernel-4/","ndl":"http://ndl.go.jp/dcndl/terms/","jpcoar":"https://github.com/JPCOAR/schema/blob/master/2.0/"},"@id":"https://cir.nii.ac.jp/crid/1380292618508564994.json","@type":"Researcher","foaf:Person":[{"foaf:name":[{"@value":"Y. Jiang"}],"foaf:familyName":[{"@value":"Jiang"}],"foaf:givenName":[{"@value":"Y."}]}],"career":[{"institution":{"notation":[{"@value":"From the Neurosciences Group, Weatherall Institute of Molecular Medicine, John Radcliffe Hospital, University of Oxford, Oxford (Drs. McKnight, Vincent, and Lang and Y. Jiang); Department of Clinical Neurology, Radcliffe Infirmary, Oxford (Drs. Hart and Palace and A. Cavey); National Hospital for Neurology and Neurosurgery, Queen Square, London, United Kingdom (Dr. Wroe); and Department of Internal Medicine B and The Center for Autoimmune Diseases, Sheba Medical Center, Tel-Hashomer, Sackler Faculty..."}]}}],"product":[{"@id":"https://cir.nii.ac.jp/crid/1360292618508564992","@type":"Article","productIdentifier":[{"@type":"DOI","@value":"10.1212/01.wnl.0000187129.66353.13"},{"@type":"URI","@value":"https://www.neurology.org/doi/pdfdirect/10.1212/01.wnl.0000187129.66353.13"}],"notation":[{"@value":"Serum antibodies in epilepsy and seizure-associated disorders"}],"relation":[{"type":"creator"}]}],"dataSourceIdentifier":[{"@type":"CROSSREF","@value":"10.1212/01.wnl.0000187129.66353.13_R06gBb574K4SGZtD7szIt0D6uOH"}]}